上海新医保药品目录执行 新增375个可报销药品

2017-12-04 东广记者 医药界

上海市2017年版基本医疗保险、工伤保险和生育保险药品目录于12月1号起正式执行。目录新增375个药品列入报销范围,肿瘤靶向药报销政策也有调整。

上海市2017年版基本医疗保险、工伤保险和生育保险药品目录于12月1号起正式执行。目录新增375个药品列入报销范围,肿瘤靶向药报销政策也有调整。

今年初人社部发布新版《国家基本医疗保险、工伤保险和生育保险药品目录》,按照国家要求,市人社局(市医保办)、市卫计委和市食药监局组织专家对本市医保药品目录进行了调整。

市人社局医保处副处长龚波介绍,新版上海医保药品目录将国家医保药品目录新增的375个药品全部列入报销范围,特别增加了部分重大疾病治疗药物,包括通过谈判大幅降价的36个国家谈判药品,大大减轻了大病患者药费负担。同时,原上海医保药品目录中的品种继续保留:

[就是说原来上海10年版药品目录一些品种没有列到国家新版的药品目录中去,这些药品,我们是继续予以保留的。同时它的支付比例、限定支付等都维持不变,延续了政策上的连续性、稳定性。]

调整后的上海医保药品目录中包含了4505种药品。龚波特别提醒参保人员,虽然目前大部分新增品种在相关医院已经配备,还有部分有需求的医院也正在陆续进药,但由于这次新增的报销药品较多,医院进药需要一个过程:

[因为品种比较多,我们讲不同医疗结构,它的特色、定位都不一样的,不是说所有医疗机构都必须配备所有医保目录的品种,没有这个必要,所以可能在我们实施的初期,老百姓在他习惯去看病的这个医院,暂时还没有配备他想用的新增的这个报销品种,这样情况之下,老百姓可以考虑到其他医疗机构去配药。]

另外,本市还同步配套公布了新的肿瘤靶向药个人定额自负标准,其中新增品种17个,下调个人定额自付标准8个,其余品种维持不变。

新版上海医保药品目录可通过上海市人力资源社会保障网、上海医保网、上海阳光医药采购网,或962218医保咨询服务热线查询。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1700576, encodeId=9a071e005760e, content=<a href='/topic/show?id=57ef3389402' target=_blank style='color:#2F92EE;'>#医保药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33894, encryptionId=57ef3389402, topicName=医保药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=158530178542, createdName=yangjxjc, createdTime=Sat Oct 27 10:19:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267497, encodeId=e6f826e497d4, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:07 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545722, encodeId=14dd1545e220d, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718013815880, createdName=ms705947299214030, createdTime=Wed Dec 06 03:19:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266759, encodeId=89fc266e59ac, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Mon Dec 04 16:25:57 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1700576, encodeId=9a071e005760e, content=<a href='/topic/show?id=57ef3389402' target=_blank style='color:#2F92EE;'>#医保药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33894, encryptionId=57ef3389402, topicName=医保药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=158530178542, createdName=yangjxjc, createdTime=Sat Oct 27 10:19:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267497, encodeId=e6f826e497d4, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:07 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545722, encodeId=14dd1545e220d, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718013815880, createdName=ms705947299214030, createdTime=Wed Dec 06 03:19:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266759, encodeId=89fc266e59ac, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Mon Dec 04 16:25:57 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
    2017-12-07 三生有幸9135

    学习一下谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1700576, encodeId=9a071e005760e, content=<a href='/topic/show?id=57ef3389402' target=_blank style='color:#2F92EE;'>#医保药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33894, encryptionId=57ef3389402, topicName=医保药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=158530178542, createdName=yangjxjc, createdTime=Sat Oct 27 10:19:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267497, encodeId=e6f826e497d4, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:07 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545722, encodeId=14dd1545e220d, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718013815880, createdName=ms705947299214030, createdTime=Wed Dec 06 03:19:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266759, encodeId=89fc266e59ac, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Mon Dec 04 16:25:57 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1700576, encodeId=9a071e005760e, content=<a href='/topic/show?id=57ef3389402' target=_blank style='color:#2F92EE;'>#医保药品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33894, encryptionId=57ef3389402, topicName=医保药品)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=158530178542, createdName=yangjxjc, createdTime=Sat Oct 27 10:19:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267497, encodeId=e6f826e497d4, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Dec 07 08:14:07 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545722, encodeId=14dd1545e220d, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718013815880, createdName=ms705947299214030, createdTime=Wed Dec 06 03:19:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266759, encodeId=89fc266e59ac, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Mon Dec 04 16:25:57 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
    2017-12-04 doctorJiangchao

    谢谢分享.

    0

相关资讯

北京将调整基本医保药品目录 740种药品昨起预备案

北京市人力社保局启动2017年北京市基本医疗保险、工伤保险和生育保险药品目录调整工作。同时,昨日起,要求相关药品进行预备案,涉及西药456种、中药284种。

外企药品降价进医保目录背后:谈判纯属自愿,提前抵御仿制药

国家第二轮药价谈判终于尘埃落定。7月19日,人力资源和社会保障部官网发布医保药品目录准入谈判结果,36个药品被纳入《国家基本医疗保险、工伤保险和生育保险药品目录(2017年版)》(以下简称“医保目录”)乙类范围。据了解,本次参与谈判的共有44个药品,最终谈判成功的有36个,成功率达到81.8%。谈判成功的36个药品包括了31个西药和5个中成药。其中,肿瘤治疗药有18个,涉及肺癌、胃癌、乳腺癌、骨髓

湿性老年黄斑变性一线药物雷珠单抗被纳入国家医保目录

国家人力资源和社会保障部公布了国家医保谈判结果,用于治疗湿性年龄相关性黄斑变性(wAMD)的一线治疗药物雷珠单抗名列其中,被纳入国家医保乙类目录。在各省级医保目录落地实施后,根据政策,一般乙类药品报销比例可达70-80%,意味着中国wAMD患者的医疗负担将被大大减轻,更多的患者将因此获益。

新药 特药进医保 企业前赴后继创新药

通过国家谈判机制,使新药、特药进入《国家医保目录》,能使社会保障机构、企业和家庭三方受益。在国家卫计委首批和第二批药品价格谈判推进下,已有39个药物捷足先登。

药价谈判力争上半年完成 将与地方目录对接

4月25日上午,人力资源和社会保障部在人社部新闻发布厅举办一季度例行新闻发布会。人社部新闻发言人卢爱红在医药领域就药品医保谈判目录相关情况、处理骗保、完善社保制度等问题做出回应和解答。

全国第二个省级医保目录调整方案出台

近日,山西省公布了《2017年基本医疗、工伤、生育保险目录整合和调整工作方案》(以下简称方案),这是青海省之后,全国第二个出台医保目录调整方案的省份。